Business ❯ Pharmaceuticals

Investment

Manufacturing Research and Development Job Creation Market Expansion AstraZeneca International Business Capacity Expansion Trade Production Facilities International Investment

Boehringer Ingelheim to Invest £150 Million in London AI Drug Discovery Centre

The decision points to warmer investor sentiment following recent UK life sciences policy shifts.

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

AstraZeneca Pledges $15 Billion China Expansion Through 2030

GSK Chief Says U.S. Is Best Place to Invest as UK Softens Drug Pricing Rules

Celltrion Details 5.4 Trillion-Won Expansion Across U.S. and Korea

Novartis to Build Radioligand Therapy Plant in Halle by 2027

U.S. Envoy Warns of Pharma Pullout as AstraZeneca Rejects UK Drug-Price Offer

GSK Eyes Big Mexico R&D Ramp-Up as It Preps Bimonthly HIV Shot for 2026

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

AstraZeneca Pauses £200 Million Expansion of Cambridge Research Site

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

Mexico Locks In Over 12 Billion Pesos in Pharmaceutical Investments Under Plan México

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

AstraZeneca Announces $50 Billion U.S. Manufacturing and R&D Expansion

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Roche Announces $50 Billion U.S. Investment to Expand R&D and Manufacturing

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub